TYMS and non-small cell lung carcinoma: Several studies indicate that high expression of the conventional pemetrexed target, TS, is associated with pemetrexed resistance.51–53 However, these observations cannot fully explain the phenomena observed in clinical NSCLC samples,54 raising the possibility that other mechanism(s) might exist, which can be responsible for pemetrexed resistance.